Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC)’s stock price shot up 1.1% on Friday . The stock traded as high as $33.17 and last traded at $33.10, 300 shares changed hands during mid-day trading. A decline of 95% from the average session volume of 6,093 shares. The stock had previously closed at $32.74.
The company’s 50 day moving average price is $28.29 and its two-hundred day moving average price is $27.24.
In other Virtus LifeSci Biotech Clinical Trials ETF news, insider Sutton Jon purchased 60,000 shares of the company’s stock in a transaction dated Monday, November 11th. The shares were acquired at an average price of $0.63 per share, for a total transaction of $37,800.00.
Featured Story: How To Calculate Debt-to-Equity Ratio
Receive News & Ratings for Virtus LifeSci Biotech Clinical Trials ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and related companies with MarketBeat.com's FREE daily email newsletter.